Solid Biosciences (SLDB) Net Income towards Common Stockholders Growth (3y) (2020 - 2026)
Solid Biosciences (SLDB) Net Income towards Common Stockholders Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-10.84% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
26.38% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-46.86% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
34.98% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Solid Biosciences |
789.54 Mn |
408.86 Mn |
- |
-22.10% |
| Date | Value |
|---|
| Mar 31, 2026 |
-22.10% |
| Dec 31, 2025 |
-12.76% |
| Sep 30, 2025 |
-30.31% |
| Jun 30, 2025 |
-15.63% |
| Mar 31, 2025 |
-14.31% |
| Dec 31, 2024 |
-26.82% |
| Sep 30, 2024 |
-22.24% |
| Jun 30, 2024 |
-10.62% |
| Mar 31, 2024 |
-12.88% |
| Dec 31, 2023 |
1.20% |
| Sep 30, 2023 |
-0.02% |
| Jun 30, 2023 |
-9.45% |
| Mar 31, 2023 |
-4.37% |
| Dec 31, 2022 |
-1.03% |
| Sep 30, 2022 |
11.38% |
| Jun 30, 2022 |
1.93% |
| Mar 31, 2022 |
5.28% |
| Dec 31, 2021 |
5.24% |
| Sep 30, 2021 |
1.76% |
| Jun 30, 2021 |
-1.31% |
